Patents by Inventor James C. Eisenach

James C. Eisenach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11771763
    Abstract: The present invention provides compositions and methods for the selective silencing of neurons in pain pathway by using a combination of inhibitory light-sensitive protein gene transfer and wavelength specific illumination.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: October 3, 2023
    Assignees: EOS NEUROSCIENCE, INC., WAKE FOREST UNIVERSITY HEALTH SCIENCES
    Inventors: Alan Horsager, Kenneth Greenberg, Benjamin C. Matteo, Edward S. Boyden, Douglas G. Ririe, James C. Eisenach, Christian Wentz
  • Publication number: 20210069329
    Abstract: The present invention provides compositions and methods for the selective silencing of neurons in pain pathway by using a combination of inhibitory light-sensitive protein gene transfer and wavelength specific illumination.
    Type: Application
    Filed: June 27, 2019
    Publication date: March 11, 2021
    Inventors: Alan Horsager, Kenneth Greenberg, Benjamin C. Matteo, Edward S. Boyden, Douglas G. Ririe, James C. Eisenach, Christian Wentz
  • Publication number: 20130225664
    Abstract: The present invention provides compositions and methods for the selective silencing of neurons in pain pathway by using a combination of inhibitory light-sensitive protein gene transfer and wavelength specific illumination.
    Type: Application
    Filed: April 5, 2011
    Publication date: August 29, 2013
    Inventors: Alan Horsager, Kenneth Greenberg, Benjamin C. Matteo, Edward S. Boyden, Douglas G. Ririe, James C. Eisenach, Christian Wentz
  • Publication number: 20030181426
    Abstract: The present invention discloses a method of eliciting an analgesic effect in a subject in need thereof comprising intrathecally administering to the subject a therapeutically effective amount of a cyclooxygenase 1 inhibitor or pharmaceutically acceptable salt thereof in a preservative-free pharmaceutically acceptable carrier. The present invention further discloses pharmaceutical compositions comprising a cylcooxygenase 1 inhibitor or a pharmaceutically acceptable salt thereof and an adjuvant such as an adrenergic agonist, opioid analgesic, local anesthetic, and calcium channel blocker, and combinations thereof in a preservative-free pharmaceutically acceptable carrier. Kits comprising a composition comprising a cyclooxygenase 1 inhibitor or a pharmaceutically acceptable salt thereof in a preservative-free pharmaceutically acceptable carrier in a container suitable for delivery of the composition into an intrathecal administration device are also disclosed herein.
    Type: Application
    Filed: February 11, 2003
    Publication date: September 25, 2003
    Inventor: James C. Eisenach
  • Patent number: 6248744
    Abstract: Patients susceptible to, or suffering from chronic and/or female-specific pain are treated by administering an effective amount of a metanicotine-based compound.
    Type: Grant
    Filed: October 5, 2000
    Date of Patent: June 19, 2001
    Assignee: Wake Forest University
    Inventor: James C. Eisenach